CTNI-64. TRIAL IN PROGRESS: DIET2TREAT -- A RANDOMIZED MULTICENTER PHASE 2 TRIAL OF A KETOGENIC DIET VS STANDARD DIETARY GUIDANCE IN COMBINATION WITH STANDARD-OF-CARE TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Publication
, Conference
Amaral, LJ; Gresham, G; Butowski, N; Peters, K; Sharma, A; Fonkem, E; Chi, J-T; Lin, P-H; Kesari, S; Shiao, S; Tighiouart, M; You, S; Hu, J ...
Published in: Neuro-Oncology
November 11, 2024
Duke Scholars
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 11, 2024
Volume
26
Issue
Supplement_8
Start / End Page
viii111 / viii112
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Amaral, L. J., Gresham, G., Butowski, N., Peters, K., Sharma, A., Fonkem, E., … Hu, J. (2024). CTNI-64. TRIAL IN PROGRESS: DIET2TREAT -- A RANDOMIZED MULTICENTER PHASE 2 TRIAL OF A KETOGENIC DIET VS STANDARD DIETARY GUIDANCE IN COMBINATION WITH STANDARD-OF-CARE TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. In Neuro-Oncology (Vol. 26, pp. viii111–viii112). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noae165.0431
Amaral, L. J., Gillian Gresham, Nicholas Butowski, Katherine Peters, Akanksha Sharma, Ekokobe Fonkem, Jen-Tsan Chi, et al. “CTNI-64. TRIAL IN PROGRESS: DIET2TREAT -- A RANDOMIZED MULTICENTER PHASE 2 TRIAL OF A KETOGENIC DIET VS STANDARD DIETARY GUIDANCE IN COMBINATION WITH STANDARD-OF-CARE TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA.” In Neuro-Oncology, 26:viii111–12. Oxford University Press (OUP), 2024. https://doi.org/10.1093/neuonc/noae165.0431.
Amaral LJ, Gresham G, Butowski N, Peters K, Sharma A, Fonkem E, et al. CTNI-64. TRIAL IN PROGRESS: DIET2TREAT -- A RANDOMIZED MULTICENTER PHASE 2 TRIAL OF A KETOGENIC DIET VS STANDARD DIETARY GUIDANCE IN COMBINATION WITH STANDARD-OF-CARE TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. In: Neuro-Oncology. Oxford University Press (OUP); 2024. p. viii111–2.
Amaral, L. J., et al. “CTNI-64. TRIAL IN PROGRESS: DIET2TREAT -- A RANDOMIZED MULTICENTER PHASE 2 TRIAL OF A KETOGENIC DIET VS STANDARD DIETARY GUIDANCE IN COMBINATION WITH STANDARD-OF-CARE TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA.” Neuro-Oncology, vol. 26, no. Supplement_8, Oxford University Press (OUP), 2024, pp. viii111–12. Crossref, doi:10.1093/neuonc/noae165.0431.
Amaral LJ, Gresham G, Butowski N, Peters K, Sharma A, Fonkem E, Chi J-T, Lin P-H, Kesari S, Shiao S, Tighiouart M, You S, Rudnick J, Freedland S, Hu J. CTNI-64. TRIAL IN PROGRESS: DIET2TREAT -- A RANDOMIZED MULTICENTER PHASE 2 TRIAL OF A KETOGENIC DIET VS STANDARD DIETARY GUIDANCE IN COMBINATION WITH STANDARD-OF-CARE TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. Neuro-Oncology. Oxford University Press (OUP); 2024. p. viii111–viii112.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 11, 2024
Volume
26
Issue
Supplement_8
Start / End Page
viii111 / viii112
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences